Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
University College London
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
cevaretigene ritoparvovec
(AAV2-RPE65) / Medical Research Council, MeiraGTx, University College London
tgAAG76
/ Armata, University College London
VSN16R
/ Ipsen, University College London